Senior Software Engineer (Front End)
Globus Medical6 months ago
Audubon, PA, USA or Methuen Town, MA, USASenior
Responsibilities
- Design and develop front-end and middle-end software for medical devices.
- Partner with Product Management and UI/UX Design on user-interface prototyping, evaluation, and implementation.
- Manage assigned work packages and complete tasks in compliance with the company’s software development environment and quality system.
- Contribute to software design verification and validation activities.
- Create and maintain assigned software design-history-file documents and assist with regulatory documentation for product or software certification when applicable.
- Attend surgical cases periodically to understand clinical context, workflows, equipment integration, and surgeon requirements.
- Complete required compliance training and follow company, legal, and ethical policies.
Requirements
- Bachelor’s degree with 5–7 years of experience in a similar role, or a master’s degree with 3–5 years of experience.
- Object-oriented C++ development experience, including C++17 and later.
- Experience with the Qt and QML frameworks.
- Experience with test-driven programming.
- Proactive, autonomous, organized, detail-oriented, and deadline-driven approach with strong problem-solving and communication skills.
- Medical-device or life-sciences experience is an asset.
- Ability to travel up to 5% of the time and attend cadaver labs and surgeries.
Benefits
- Travel is expected up to 5% of the time, including attendance at cadaver labs and surgeries.
About Globus Medical
Globus Medical builds musculoskeletal medical devices, including spinal and orthopedic trauma implants, biomaterials, and enabling technologies such as the ExcelsiusGPS robotic navigation system, sold to hospitals and surgeons. The company generates revenue through the sale of implants, instruments, and related software and services used in surgery. Founded in 2003 and headquartered in Audubon, Pennsylvania, it is publicly traded on the NYSE (GMED) and in 2023 combined with NuVasive to expand its spine portfolio.